- CATX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Perspective Therapeutics (CATX) CORRESPCorrespondence with SEC
Filed: 13 Dec 23, 12:00am
PERSPECTIVE THERAPEUTICS, INC.
2401 Elliott Avenue, Suite 320
Seattle, Washington 98121
December 13, 2023
VIA EDGAR
Office of Industrial Applications and Services
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Benjamin Richie
Margaret Schwartz
Re: | Perspective Therapeutics, Inc. |
Registration Statement on Form S-3, as amended |
Filed November 17, 2023 |
File No. 333-275638 |
Request for Acceleration of Effective Date |
To Whom it May Concern,
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Perspective Therapeutics, Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 and declare such Registration Statement effective as of 4:00 p.m., Eastern Time, on December 14, 2023, or as soon thereafter as possible.
Please direct any questions or comments concerning this request to Stephen M. Nicolai of Hogan Lovells US LLP at (267) 675-4642. Also, please notify Mr. Nicolai when this request for acceleration has been granted.
Very truly yours,
PERSPECTIVE THERAPEUTICS, INC.
By: /s/ Johan (Thijs) Spoor Name: Johan (Thijs) Spoor Title: Chief Executive Officer |